We are creating some awesome events for you. Kindly bear with us.

NTU research team creates organic “tracking” nanoagents to monitor very small diseased tissues

NTU research team creates organic “tracking” nanoagents to monitor very small diseased tissues

Featured image: NTU Assoc Prof Pu Kanyi shining a UV light
at the nanoagents. Credit: NTU

Polymer nanoagents that can ‘light up’ tiny areas of
diseased tissues that conventional methods fail to detect, have been created by
a research team led by Nanyang Technological University, Singapore (NTU

The nanoagents, known as ‘semiconductor polymer
nanoparticles’ (SPNs), can store light energy from sources such as sunlight,
near-infrared light or even light from mobile phones, and then emit long-lasting
‘afterglow light’.

The research team from NTU Singapore tailored highly
sensitive SPNs to track down and lock on to diseased tissues in the body such
as cancerous cells, sending back near-infrared signals which can be received
and interpreted by standard imaging equipment.

Scientists and doctors now have more time to look at test
results, as the nanoagents continue self-illuminating and their light intensity
decreases by half only after six minutes.

Alternatively, if stored at -20 degrees Celsius, the sample
will maintain its results for a month, making it convenient for other
diagnostic experts to interpret and review the results at a later time.

When tested in mice, the method provided results 20 to 120
times more sensitive than current optical imaging methods and 10 times faster
in showing up diseased tissues.

Unlike conventional optical afterglow agents that are less
bright and contain rare-earth heavy-metal ions that are toxic to biological
cells, the new nanoagents are also organic, biodegradable and contain
biologically benign ingredients that are non-toxic.

The research was published in the scientific journal Nature
Biotechnology on October 16 2017. It could lead to future potential
applications in image-guided surgery and in monitoring the effects of drugs
that are seeking regulatory approval.

Associate Professor Pu Kanyi from NTU’s School of Chemical
and Biomedical Engineering, who led the research team, said, “The new polymer
nanoagents we have designed and built show a great deal of promise for clinical
applications. They can detect diseased tissue much faster than current optical
imaging techniques, and are much safer to use.

“We hope this may lead to technology that allows doctors to
diagnose and treat patients much earlier than is possible at present. Potential
use may be in image-guided surgery, where surgeons could use the technology to
help them precisely remove diseased tissues in real-time, and in monitoring the
effects of drugs that are seeking regulatory approval.”

Role in drug development

The technology can also be used to evaluate the behaviour
and therapeutic outcomes of drugs in the body, for example, whether drugs
induce liver damage as a side effect. 

liver damage
is one of the most common reasons that the US Food and Drug
Administration withholds drug approval.

Evaluation of potential damage in advance of regulatory
approval is challenging because currently, studies performed in a controlled
environment outside of a living organism often have low predictive power of how
the drug reacts inside the organism.

Existing methods only track such activity at the tissue
level whereas the new technology works at a molecular level, monitoring increased
or decreased levels of biomarkers to determine how the drugs are working,
before their therapeutic action is complete, providing much greater predictive
power for drug development. 

The study took two years and a patent is being filed for the
technology. The research team now intends to conduct further trials in larger
animal models.

The research team included researchers from the National
University of Singapore and the University of California San Diego.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit www.planview.com.


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.

Send this to a friend